Pro-inflammatory effects of early non-enzymatic glycated proteins in human mesothelial cells vary with cell donor's age

British Journal of Pharmacology

Volumn 149, Issue 8, 2006, Pages 979-987

  Rodriguez Manas L ^a   Sanchez Rodriguez C ^a   Vallejo, S ^a   El Assar, M ^a   Peiro C ^b   Azcutia, V ^b   Matesanz, N ^b   Sanchez Ferrer C F ^b   Nevado, J ^a  

^a HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Ageing; Amadori adducts; Diabetes; Glycated human haemoglobin; Human mesothelial cells; Inflammatory response; Nitric oxide; Nuclear factor B

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; GLYCOSYLATED ALBUMIN; GLYCOSYLATED HEMOGLOBIN; GLYCOSYLATED PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; AGE DISTRIBUTION; AGED; AGING; ARTICLE; CELL CULTURE; CELL ISOLATION; CONTROLLED STUDY; CULTURE MEDIUM; DIABETES MELLITUS; DONOR; HUMAN; HUMAN CELL; INFLAMMATION; MESOTHELIUM CELL; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE INJURY;

ADULT; AGED; AGED, 80 AND OVER; AGING; CELLS, CULTURED; CYCLOOXYGENASE 2; CYTOKINES; EPITHELIUM; GENES, REPORTER; GLYCOPROTEINS; HUMANS; INFLAMMATION; LUCIFERASES; MIDDLE AGED; NF-KAPPA B; NITRATES; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; OMENTUM; PLASMIDS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RNA; TRANSFECTION;

EID: 33845605922     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706864     Document Type: Article

References (31)

1. Amore A, Cirina P, Mitola S, Peruzzi L, Gianoglio B, Rabbone I et al. (1997). Nonenzymatically glycated albumin (Amadori adducts) enhances nitric oxide synthase activity and gene expression in endothelial cells. Kidney Int 51: 27-35.
2. Angulo J, Sánchez-Ferrer CF, Peiró C, Marín J, Rodríguez-Mañas L (1996). Impairment of endothelium-dependent relaxations by increasing percentages of glycated human haemoglobin. Hypertension 28: 583-592.
3. Bodega F, Zacchi L, Agostini E (2002). Albumin transcytosis in mesothelium. Am J Physiol Lung Cell Mol Physiol 282: L3-L11.
4. Cerami A, Vlassara H, Brownlee M (1998). Role of advanced glycosylation products in complications of diabetes. Diabetes Care 1: 73-79.
5. Chung-Welch N, Patton WF, Shepro D, Cambria RP (1997). Two-stage isolation procedure for obtaining homogenous populations of microvascular endothelial and mesothelial cells from human omentum. Microvascular Res 54: 121-134.
6. De Groot J, Verzijl N, Wenting-van Wijk MJ, Jacobs KM, Van Roermund PM, Bank RA et al. (2004). Accumulation of AGEs as a molecular mechanism of aging as a risk factor in osteoarthritis. Arthritis Rheum 50: 1207-1215.
7. Ferrucci L, Ble A, Bandinelli S, Lauretani F, Suthers K, Guralnik JM (2004). A flame burning within. Aging Clin Exp Res 16: 240-243.
8. Friedlander MA, Wu YC, Elgawish A, Monnier VM (1996). Early and advanced glycosylation end-products. Kinetics of formation and clearance in peritoneal dialysis. J Clin Invest 97: 728-735.
9. Fries DM, Paxinou E, Themistocleous M, Swanberg E, Griendling KK, Salvemini D et al. (2003). Expression of inducible nitric-oxide synthase and intracellular protein tyrosine nitration in vascular smooth muscle cells. J Biol Chem 25: 22901-22907.
10. Go EK, Jun KJ, Kim JY, Yu BP, Chung HY (2005). Betaine supresses proinflammatory signaling during aging: the involvement of nuclear factor-κB via nuclear factor-inducing kinase/IκB kinase and mitogen-activated protein kinases. J Gerontol: Biol Sci 60A: 1252-1264.
11. Hattori Y, Suziki M, Hattori S, Kasai K (2002). Vascular smooth muscle cell activation by glycated albumin (Amadori adducts). Hypertension 39: 22-28.
12. Inoue H, Yokoyama C, Hara S, Tone Y, Tanabe T (1995). Transcriptional regulation of human prostaglandin-endoperoxide synthase-2 gene by lipopolysaccharide and phorbol ester in vascular endothelial cells. Involvement of both nuclear factor for interleukin-6 expression site and cAMP response element. J Biol Chem 270: 24965-24971.
13. Luth HJ, Ogunlade V, Kuhla B, Kientsch-Engel R, Stahl P, Webster J et al. (2005). Age- and stage-dependent accumulation of advanced glycation end products in intracellular deposits in normal and Alzheimer's disease brains. Cereb Cortex 15: 211-220.
14. Maggi S, Noale M, Gallina P, Marzari C, Bianchi D, Limongi F et al., ILSA Group (2004). Physical disability among older Italians with diabetes The ILSA study. Diabetologia 47: 1957-1962.
15. Mandl-Weber S, Haslinger B, Schalkwijk CG, Sitter T (2001). Early glycated albumin, but not advanced glycated albumin, methylglyoxal, or 3-deoxyglucosonee increases the expression of PAI-1 in human peritoneal mesothelial cells. Perit Dial Int 21: 487-494.
16. Nevado J, Peiró C, Vallejo S, El-Assar M, Lafuente N, Matesanz N et al. (2005). Amadori adducts activate NF-κB-related pro-inflammatory genes in human peritoneal mesothelial cells. Br J Pharmacol 146: 268-279.
17. Nevado J, Vallejo S, El-Assar M, Peiró C, Sánchez-Ferrer CF, Rodríguez-Mañas L (2006). Changes in the human peritoneal mesothelial cells during aging. Kidney Int 69: 313-322.
18. Ney KA, Colley KJ, Pizzo SV (1981). The standardization of the thiobarbituric acid assay for nonenzymatic glucosylation of human serum albumin. Anal Biochem 118: 294-300.
19. Park MS, Lee HA, Chu WS, Yang DH, Hwang SD (2000). Peritoneal accumulation of AGE and peritoneal membrane permeability. Perit Dial Int 20: 452-460.
20. Peiró C, Angulo J, Rodríguez-Mañas L, Llergo JL, Vallejo S, Cercas E et al. (1998). Vascular smooth muscle cell hypertrophy induced by glycosylated human oxyhaemoglobin. Br J Pharmacol 125: 637-644.
21. Peiró C, Matesanz N, Nevado J, Lafuente N, Cercas E, Azcutia V et al. (2003). Glycated human oxyhaemoglobin activates nuclear factor-κB and activator protein-1 in cultured human aortic smooth muscle. Br J Pharmacol 140: 681-690.
22. Posthuma N, ter Wee PM, Niessen H, Donker AJ, Vernrugh HA, Schalkwijk CG (2001). Amadori albumin and advanced glycation end-product formation in peritoneal dialysis using icodextrin. Perit Dial Int 21: 43-51.
23. Rodríguez-Mañas L, Angulo J, Vallejo S, Peiró C, Sánchez-Ferrer A, Cercas E et al. (2003). Early and intermediate amadori glycated adducts oxidative stress, and endothelial dysfunction in the streptozotocin-induced diabetic rat's vasculature. Diabetologia 46: 556-566.
24. Ruiz-Torres A, Lozano R, Melon J, Carraro R (2003). Age-dependent decline of in vitro migration (basal and stimulated by IGF-1 or insulin) of human vascular smooth muscle cells. J Gerontol: Biol Sci 58A: 1074-1077.
25. Sarkar D, Lebedeva IV, Emdad L, Kang DC, Baldwin Jr AS, Fisher PB (2004). Human polynucleotide phosphorylase (hPNPaseold-35): a potential link between aging and inflammation. Cancer Res 64: 7473-7478.
26. Sell DR, Monnier VM (1989). Structure elucidation of a senescence cross-link from human extracellular matrix. Implications of pentoses in the aging process. J Biol Chem 264: 21597-21602.
27. Taylor BS, de Vera ME, Ganster RW, Wang K, Shapiro RA, Morris Jr SM et al. (1998). Multiple NF-κB enhancer elements regulate cytokine induction of human inducible nitric oxide synthase gene. J Biol Chem 273: 15148-15156.
28. Tietz NW (1990). Clinical Guide to Laboratory Tests. WB Saunders Co.: Philadelphia, PA, pp 284-285.
29. Vallejo S, Angulo J, Peiró C, Nevado J, Sánchez-Ferrer A, Petidier R et al. (2000). Highly glycated oxyhemoglobin impairs nitric oxide relaxations in human mesenteric microvessels. Diabetologia 43: 83-90.
30. Wu CH, Huang CM, Lin CH, Ho YS, Chen CM, Lee HM (2002). Advanced glycosylation end products induce NF-kappaB dependent iNOS expression in RAW 264.7 cells. Mol Cell Endocrinol 194: 9-17.
31. Yañez-Mo M, Lara-Pezzi E, Selgas R, Ramírez-Huesca M, Domínguez-Jiménez C, Jiménez-Heffernan A et al (2003). Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl J Med 348: 403-412.